ProjectResmain Study
Basic data
Title:
Resmain Study
Duration:
03/07/2017 to 31/12/2019
Abstract / short description:
A multicentre, double blind, randomised, placebo
controlled, Phase II trial to evaluate
Resminostat for maintenance treatment of
patients with advanced stage (Stage IIB IVB)
mycosis fungoides (MF) or Sézary Syndrome
(SS) that have achieved disease control with
systemic therapy – the RESMAIN Study
controlled, Phase II trial to evaluate
Resminostat for maintenance treatment of
patients with advanced stage (Stage IIB IVB)
mycosis fungoides (MF) or Sézary Syndrome
(SS) that have achieved disease control with
systemic therapy – the RESMAIN Study
Keywords:
dermatology
Dermatologie
skin diseases
Hautkrankheiten
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Contact persons
Universität Tübingen
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Dublin, Ireland